(Q42825125)
Statements
Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation (English)
Inderjit Mehmi
Vishal A Verma
Poh K Teng